CRNX CRINETICS PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2024 - Stock Offering Crinetics Pharmaceuticals, Inc. has entered into an underwriting agreement to sell 10 million shares of common stock at $50.00 per share, expecting to raise approximately $472 million, or $542.9 million if the underwriters exercise their option for additional shares.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC